Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jeanette K Birnbaum"'
Publikováno v:
The Lancet Global Health, Vol 6, Iss 8, Pp e885-e893 (2018)
Summary: Background: Poor breast cancer survival in low-income and middle-income countries (LMICs) can be attributed to advanced-stage presentation and poor access to systemic therapy. We aimed to estimate the outcomes of different early detection st
Externí odkaz:
https://doaj.org/article/ea526165370d46588de31c9743e53086
Autor:
Ian E Fellows, Martina Morris, Jeanette K Birnbaum, Julia C Dombrowski, Susan Buskin, Amy Bennett, Matthew R Golden
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197707 (2018)
[This corrects the article DOI: 10.1371/journal.pone.0129551.].
Externí odkaz:
https://doaj.org/article/fef71d959d2740799a85c469763d78af
Autor:
Ian E Fellows, Martina Morris, Jeanette K Birnbaum, Julia C Dombrowski, Susan Buskin, Amy Bennett, Matthew R Golden
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135878 (2015)
Externí odkaz:
https://doaj.org/article/ae990cd1b7a74eb08e7175bc4091e411
Autor:
Ian E Fellows, Martina Morris, Jeanette K Birnbaum, Julia C Dombrowski, Susan Buskin, Amy Bennett, Matthew R Golden
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0129551 (2015)
We develop a new approach for estimating the undiagnosed fraction of HIV cases, the first step in the HIV Care Cascade. The goal is to address a critical blindspot in HIV prevention and treatment planning, with an approach that simplifies data requir
Externí odkaz:
https://doaj.org/article/388755d95cc14ff6aa9d2c2bda3b0c3b
Autor:
Ruth Etzioni, John T. Wei, Yair Lotan, Jing Fan, Roman Gulati, Ziding Feng, Jeanette K. Birnbaum
Background: New biomarkers for early detection of cancer must pass through several phases of development. Early phases provide information on diagnostic properties but not on population benefits and harms. Prostate cancer antigen 3 (PCA3) is a promis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b60edf9e5c8ef3da0eb3f1a7d676439
https://doi.org/10.1158/1055-9965.c.6515500.v1
https://doi.org/10.1158/1055-9965.c.6515500.v1
Autor:
Ruth Etzioni, John T. Wei, Yair Lotan, Jing Fan, Roman Gulati, Ziding Feng, Jeanette K. Birnbaum
Supplementary Table 1 - Data and assumptions used to construct each element of the natural history model of prostate cancer and the extension incorporating PCA3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477817d5f9b4f8d0546eb5f59ce3a478
https://doi.org/10.1158/1055-9965.22436626
https://doi.org/10.1158/1055-9965.22436626
Autor:
Julia C. Dombrowski, Susan E. Buskin, Martina Morris, Matthew R. Golden, Jeanette K. Birnbaum, Amy B. Bennett, Ian Fellows
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 5, p e0197707 (2018)
PLoS ONE, Vol 10, Iss 8, p e0135878 (2015)
PLoS ONE, Vol 10, Iss 7, p e0129551 (2015)
PLoS ONE, Vol 13, Iss 5, p e0197707 (2018)
PLoS ONE, Vol 10, Iss 8, p e0135878 (2015)
PLoS ONE, Vol 10, Iss 7, p e0129551 (2015)
We develop a new approach for estimating the undiagnosed fraction of HIV cases, the first step in the HIV Care Cascade. The goal is to address a critical blindspot in HIV prevention and treatment planning, with an approach that simplifies data requir
Publikováno v:
Annals of internal medicine. 164(4)
Mammography trials, which are the primary sources of evidence for screening benefit, were conducted decades ago. Whether advances in systemic therapies have rendered previously observed benefits of screening less significant is unknown.To compare the
Publikováno v:
Bulletin of the World Health Organization. 89:278-285
OBJECTIVE: To quantify the deaths from human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) that are misattributed to other causes in South Africa's death registration data and to adjust for this bias. METHODS: De
Autor:
Leslie Mallinger, Jeanette K. Birnbaum, Ruth Etzioni, Josh J. Carlson, Foluso O. Ademuyiwa, Mark W. Mason
Background. Biomarkers used at the time of diagnosis to tailor treatment decisions may diffuse into clinical practice before data become available on whether biomarker testing reduces cancer mortality. In the interim, quantitative estimates of the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411901761494b39c0e436118d80e949f
https://europepmc.org/articles/PMC4766067/
https://europepmc.org/articles/PMC4766067/